Ranked #4,014 of 8,699 institutional investors
venBio Partners LLC
San Francisco, CA
$431M
US stock portfolio at live prices · today −$4.3M (−1.00%)
Market closed. Prices as of Nov 20, 7:41 AM ET
- Value at quarter end (Q3 2026)
- $496M
- Change from Q2 2026
- −$23.5M (−4.52%)
- Positions
- 8 · 3 new, 1 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$141M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesPBLS 33.8%ATTO 15.1%QUIT 8.06%ALMS 4.21%ALXO 3.05%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| PBLS Parabilis Medicines, Inc. | 5,266,697 | $145M | 33.8% | Unchanged |
| ATTO Attovia Therapeutics, Inc. | 4,181,366 | $65.1M | 15.1% | New |
| QUIT Achieve Life Sciences, Inc. | 5,914,720 | $34.7M | 8.06% | Unchanged |
| ALMS Alumis Inc. | 4,191,408 | $18.1M | 4.21% | Reduced −7% |
| ALXO ALX Oncology Holdings Inc. | 12,884,638 | $13.1M | 3.05% | Unchanged |
| YARW Yarrow Bioscience, Inc. | 554,769 | $7.9M | 1.83% | New |
| LYEL Lyell Immunopharma, Inc. | 337,697 | $4.6M | 1.06% | Unchanged |
| LSTA Lisata Therapeutics, Inc. | 156,460 | $142K | <0.1% | New |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| HRMY Harmony Biosciences Holdings, Inc. | 472,194 | $15.6M |